Here, we show that administration of G‐CSF and SCF have marked direct neuroprotective effects in a “humanized” mouse model of Friedreich's ataxia; these agents correct many Friedreich's ataxia–associated biochemical abnormalities and improve functional, neurophysiological, and pathological parameters. This evidence concerns the gene CSF3 and Friedreich ataxia.